Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study

被引：0
|
作者：
Ortega, Hector
Liu, Mark
Pavord, Ian
Brusselle, Guy
FitzGerald, J. Mark
Chetta, Alfredo
Katz, Lynn
Keene, Oliver
Yancey, Steven
Chanez, Pascal
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Exacerbation; Asthma; -; management; Inflammation;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2906
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Secondary loss of response to mepolizumab in severe eosinophilic asthma
    Cormier, Maxime
    Chaboillez, Simone
    Lemiere, Catherine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 736 - 738
  • [42] Clinical response to mepolizumab in patients with severe eosinophilic asthma
    Harvey, Erin
    Langton, David L.
    Powell, Heather
    Gibson, Peter G.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [43] Impact of Mepolizumab on Airway Remodelling in Severe Eosinophilic Asthma
    Taille, C.
    Hamidi, F.
    Heddebaut, N.
    Dupin, C.
    Le Guen, P.
    Le Brun, M.
    Pote, N.
    Cazes, A.
    Roy, C.
    Dupont, A.
    Letuve, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [44] Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis
    Crimi, Claudia
    Campisi, Raffaele
    Cacopardo, Giulia
    Doria, Giacomo
    Intravaia, Rossella
    Morena, Porto
    Sabrina, Genco
    Sorrentino, Ramona
    Crimi, Nunzio
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [45] Improvement of lung function measured by AM PEF in patients with severe eosinophilic asthma treated with mepolizumab: A combined analysis of the MENSA and MUSCA studies
    Ortega, Hector
    Menzies-Gow, Andrew
    Llanos-Ackert, Jean-Pierre
    Forshag, Mark S.
    Albers, Frank C.
    Gunsoy, Necdet
    Bradford, Eric
    Yancey, Steven W.
    Kraft, Monica
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB16 - AB16
  • [46] REDES study: Mepolizumab is effective in patients with severe eosinophilic asthma and comorbid NP
    Nunez, E. Arismendi
    Cisneros, C.
    Blanco-Aparicio, M.
    Conejero, D. Banas
    Moure, A. L.
    Sanchez-Herrero, M. G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [47] Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study
    Pavord, Ian
    Gardiner, Frances
    Heaney, Liam G.
    Domingo, Christian
    Price, Robert G.
    Pullan, Alison
    Oppenheimer, John
    Brusselle, Guy
    Nagase, Hiroyuki
    Chupp, Geoffrey
    Pizzichini, Emilio
    Banas-Conejero, David
    Howarth, Peter
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma (vol 360, pg 973, 2009)
    Pranabashis, Haldar
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 588 - 588
  • [49] Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
    Shimoda, Terufumi
    Odajima, Hiroshi
    Okamasa, Arisa
    Kawase, Minako
    Komatsubara, Masaki
    Mayer, Bhabita
    Yancey, Steven
    Ortega, Hector
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (03) : 445 - 451
  • [50] Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility
    Humbert, Marc
    Albers, Frank C.
    Bratton, Daniel J.
    Yancey, Steven W.
    Liu, Mark C.
    Hozawa, Soichiro
    Llanos, Jean-Pierre
    Kwon, Namhee
    RESPIRATORY MEDICINE, 2019, 154 : 69 - 75
12345